SCHEMBL30955697

SCHEMBL30955697

O=S(=O)(c1ccccc1)n1ccc2cnc(Cl)nc21

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.58
PKM P14618 1/20 0.51
HTR6 P50406 10/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50
FGFR4 P22455 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.45
MET P08581 1/20 0.44
POLB P06746 1/20 0.41
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29229341 1.00 CYP2C19 (0.58) CYP2C19PKMHTR6MEN1KMT2A
SCHEMBL17844813 0.86 L3MBTL1 (0.59) CYP2C19PKMHTR6KMT2AALDH1A1
SCHEMBL30684920 0.82 CYP2C19 (0.58) CYP2C19PKMHTR6MEN1KMT2A
SCHEMBL30685172 0.81 FGFR4 (0.57) HTR6MEN1KMT2AFGFR4L3MBTL1
SCHEMBL29277237 0.81 FGFR4 (0.57) HTR6MEN1KMT2AFGFR4L3MBTL1
SCHEMBL2011040 0.79 CYP2C19 (0.61) CYP2C19PKMHTR6MEN1KMT2A
SCHEMBL17714319 0.78 MET (0.57) CYP2C19PKMHTR6MEN1KMT2A
SCHEMBL10142546 0.78 CYP2C19 (0.61) CYP2C19PKMHTR6MEN1KMT2A
SCHEMBL16580886 0.78 FGFR4 (0.41) CYP2C19PKMALDH1A1TSHRHTT
SCHEMBL27891832 0.78 CYP2C19 (0.64) CYP2C19PKMHTR6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070915-A1 SUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINES AS SELECTIVE CDK2/4 INHIBITORS INCYTE CORP (US) 2026-03-12 US disclosed
WO-2024131893-A1 IRE1α SMALL MOLECULE INHIBITORS SHANGHAI YI ZHONG XING BIOTECHNOLOGY CO., LTD. (CN) 2024-06-27 WO disclosed
CN-118184658-A USP1 inhibitors 上海齐鲁制药研究中心有限公司 2024-06-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070915-A1 SUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINES AS SELECTIVE CDK2/4 INHIBITORS CDK4, CDK2, CCNC CYP2C19 1448/4885PKM 1757/4885HTR6 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.